Man Group
VIR icon

Man Group’s Vir Biotechnology VIR Stock Holding History

Man Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
150,688
-27,236
-15% -$259K ﹤0.01% 1686
2026
Q1 		$1.59M Buy
+177,924
New +$1.42M ﹤0.01% 1664
2025
Q4 		– Sell
-70,477
Closed -$402K – 2488
2025
Q3 		$402K Sell
70,477
-186,441
-73% -$953K ﹤0.01% 1917
2025
Q2 		$1.29M Buy
256,918
+164,727
+179% +$883K ﹤0.01% 1555
2025
Q1 		$597K Buy
+92,191
New +$820K ﹤0.01% 1736
2023
Q3 		– Sell
-297,527
Closed -$4.24M – 1816
2023
Q2 		$7.3M Buy
+297,527
New +$7.47M 0.02% 740
2023
Q1 		– Sell
-67,344
Closed -$1.72M – 643
2022
Q4 		$1.7M Sell
67,344
-93,895
-58% -$2.3M 0.01% 1160
2022
Q3 		$3.11M Buy
+161,239
New +$4.1M 0.01% 917
2022
Q2 		– Sell
-166,391
Closed -$3.88M – 574
2022
Q1 		$4.28M Buy
166,391
+109,637
+193% +$3.25M 0.01% 947
2021
Q4 		$2.38M Buy
56,754
+43,522
+329% +$1.71M 0.01% 1130
2021
Q3 		$575K Buy
13,232
+5,224
+65% +$226K ﹤0.01% 1497
2021
Q2 		$378K Buy
8,008
+695
+10% +$31.6K ﹤0.01% 1631
2021
Q1 		$375K Sell
7,313
-9,818
-57% -$529K ﹤0.01% 1575
2020
Q4 		$458K Buy
+17,131
New +$557K ﹤0.01% 1575
2020
Q3 		– Sell
-39,407
Closed -$1.61M – 1885
2020
Q2 		$1.61M Buy
+39,407
New +$1.32M 0.01% 1131

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Man Group's VIR Position: Q2 2026 in Review

Man Group reduced its Vir Biotechnology (VIR) stake by 15% in Q2 2026, selling an estimated $259K and leaving 150,688 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Man Group first reported a position in VIR in Q2 2020 and has held it in 15 quarters since. The position peaked at $7.3M in Q2 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Man Group held 150,688 shares of Vir Biotechnology worth $1.54M as of Q2 2026.
  • Man Group sold 27,236 Vir Biotechnology shares in Q2 2026, an estimated $259K.
  • Vir Biotechnology made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1686 holding.
  • Man Group first reported a position in Vir Biotechnology in Q2 2020 and has held it in 15 quarters since.
  • Man Group's Vir Biotechnology position peaked at $7.3M in Q2 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.